Showing 1 - 5 results of 5 for search 'Jakob Michael Riedl', query time: 0.02s Refine Results
  1. 1
    External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients

    External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients by Dominik Andreas Barth, Carina Brenner, Jakob Michael Riedl, Felix Prinz, Eva Valentina Klocker, Konstantin Schlick, Peter Kornprat, Karoline Lackner, Herbert Stöger, Michael Stotz, Armin Gerger, Martin Pichler

    Published 2020-08-01
    Get full text
    Article
  2. 2
    Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study

    Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study by Jakob Michael Riedl, Florian Posch, Angelika Bezan, Joanna Szkandera, Maria Anna Smolle, Thomas Winder, Christopher H. Rossmann, Renate Schaberl-Moser, Martin Pichler, Michael Stotz, Herbert Stöger, Armin Gerger

    Published 2017-06-01
    Get full text
    Article
  3. 3
    Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients

    Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients by Eva Valentina Klocker, Dominik Andreas Barth, Jakob Michael Riedl, Felix Prinz, Joanna Szkandera, Konstantin Schlick, Peter Kornprat, Karoline Lackner, Jörg Lindenmann, Herbert Stöger, Michael Stotz, Armin Gerger, Martin Pichler

    Published 2020-05-01
    Get full text
    Article
  4. 4
    The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: analysis of an Austrian multicenter, noninterventional study

    The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: analysis of an Austrian multicent... by Jakob Michael Riedl, Florian Posch, Gerald Prager, Wolfgang Eisterer, Leopold Oehler, Thamer Sliwa, Klaus Wilthoner, Andreas Petzer, Petra Pichler, Eva Hubmann, Thomas Winder, Sonja Burgstaller, Markus Korger, Johannes Andel, Richard Greil, Hans-Joerg Neumann, Martin Pecherstorfer, Kathrin Philipp-Abbrederis, Angela Djanani, Birgit Gruenberger, Friedrich Laengle, Ewald Wöll, Armin Gerger

    Published 2020-04-01
    Get full text
    Article
  5. 5
    Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study

    Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort st... by Matthias Preusser, Erika Richtig, Florian Moik, Cihan Ay, Martin Pichler, Florian Posch, Armin Gerger, Lukas Koch, Thomas Bauernhofer, Thomas Winder, Dominik A Barth, Sarah Steinlechner, Marie-Christina Mayer, Amelie M Sandner, Franziska Berton, Verena Schlintl, Nikolaus John, Robert Wurm, Patrick Reimann, Christoph Wohlkönig, Philipp J Jost, Angelika Terbuch, Jakob Michael Riedl

    Published 2023-12-01
    Get full text
    Article

Search Tools: